Zilovertamab Vedotin Biosimilar - Research Grade

Human

ROR1

1mg/ml

IgG1

CHO Cells

Q01973

Room Temp

ROR1 is an oncofetal receptor tyrosine kinase re-expressed on tumour cells while largely absent from normal adult tissue, supporting antibody-directed payload delivery in oncology research. This research-grade reagent is an unconjugated, non-therapeutic analog of zilovertamab vedotin built around ROR1 and supplied for research use only (RUO). It is manufactured to in vivo standards with low endotoxin and is available in scalable milligram (mg) to gram (g) quantities for heavy-usage laboratories. As an ADC-format research tool, it is well suited to antibody-drug conjugate development, in vitro internalisation and cytotoxicity assays, and in vivo preclinical tumour models.

MMAE

25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

1 week